{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T01:11:10Z","timestamp":1768266670308,"version":"3.49.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,3]],"date-time":"2017-08-03T00:00:00Z","timestamp":1501718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.vhri.2017.07.009","type":"journal-article","created":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T08:30:37Z","timestamp":1504254637000},"page":"56-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Resource Use and Cost of Treating Human Papillomavirus\u2013Related Lesions in Japanese Women"],"prefix":"10.1016","volume":"15","author":[{"given":"Akiko","family":"Mizukami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiko","family":"Kaise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georges","family":"Van Kriekinge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vhri.2017.07.009_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.vhri.2017.07.009_bib2","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1470-2045(12)70137-7","article-title":"Global burden of cancers attributable to infections in 2008: a review and synthetic analysis","volume":"13","author":"de Martel","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.vhri.2017.07.009_bib3","unstructured":"Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0. Cancer incidence and mortality worldwide: IARC Cancer Base No. 11. 2013. Available from: http:\/\/globocan.iarc.fr. [Accessed January 31, 2014]."},{"key":"10.1016\/j.vhri.2017.07.009_bib4","unstructured":"Cancer Information Service. Cancer statistics in Japan: national estimates of cancer incidence based on cancer registries in Japan (1975\u20132012). 2016. Available from: http:\/\/ganjoho.jp\/professional\/statistics\/statistics.html. [Accessed May 24, 2017]."},{"key":"10.1016\/j.vhri.2017.07.009_bib5","first-page":"17","article-title":"National surveillance of sexually transmitted diseases of Japan in 2002","volume":"15","author":"Kumamoto","year":"2004","journal-title":"Jpn J Sex Transm Dis"},{"key":"10.1016\/j.vhri.2017.07.009_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2334-13-39","article-title":"Systematic review of the incidence and prevalence of genital warts","volume":"13","author":"Patel","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vhri.2017.07.009_bib7","first-page":"1017","article-title":"Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection","volume":"164","author":"Franco","year":"2001","journal-title":"CMAJ"},{"key":"10.1016\/j.vhri.2017.07.009_bib8","doi-asserted-by":"crossref","first-page":"482","DOI":"10.5694\/j.1326-5377.2006.tb00661.x","article-title":"Cervical cancer in Australia and the United Kingdom: comparison of screening policy and uptake, and cancer incidence and mortality","volume":"185","author":"Canfell","year":"2006","journal-title":"Med J Aust"},{"issue":"Suppl. 1","key":"10.1016\/j.vhri.2017.07.009_bib9","doi-asserted-by":"crossref","first-page":"i44","DOI":"10.1093\/jjco\/hyq126","article-title":"Cervical Cancer Working Group report","volume":"40","author":"Konno","year":"2010","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.vhri.2017.07.009_bib10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/jjco\/hyq036","article-title":"The Japanese guideline for cervical cancer screening","volume":"40","author":"Hamashima","year":"2010","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.vhri.2017.07.009_bib11","unstructured":"Official Statistics of Japan. Examination status of cancer screening. Comprehensive survey of living conditions (2010). 2013. Available from: http:\/\/www.e-stat.go.jp\/SG1\/estat\/eStatTopPortal.do. [Accessed August 17, 2014]."},{"key":"10.1016\/j.vhri.2017.07.009_bib12","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2188\/jea.JE20140080","article-title":"Evaluation of a free-coupon program for cervical cancer screening among the young: a nationally funded program conducted by a local government in Japan","volume":"25","author":"Ueda","year":"2015","journal-title":"J Epidemiol"},{"key":"10.1016\/j.vhri.2017.07.009_bib13","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/ijc.28095","article-title":"Does removal of out-of-pocket costs for cervical and breast cancer screening work? A quasi-experimental study to evaluate the impact on attendance, attendance inequality and average cost per uptake of a Japanese government intervention","volume":"133","author":"Tabuchi","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vhri.2017.07.009_bib14","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1111\/jog.13122","article-title":"Project conducted in Hirakata to improve cervical cancer screening rates in 20-year-old Japanese: influencing parents to recommend that their daughters undergo cervical cancer screening","volume":"42","author":"Yagi","year":"2016","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/j.vhri.2017.07.009_bib15","unstructured":"Bruni L, Barrionuevo-Rosas L, Albero G, et al. Human papillomavirus and related diseases in Japan: summary report. 2017. Available from: http:\/\/hpvcentre.net\/index.php. [Accessed May 3, 2017]."},{"key":"10.1016\/j.vhri.2017.07.009_bib16","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1524-4733.2007.00186.x","article-title":"Using real-world data for coverage and payment decisions: the ISPOR Real-World Data Task Force Report","volume":"10","author":"Garrison","year":"2007","journal-title":"Value Health"},{"key":"10.1016\/j.vhri.2017.07.009_bib17","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2188\/jea.JE20090066","article-title":"Development of a database of health insurance claims: standardization of disease classifications and anonymous record linkage","volume":"20","author":"Kimura","year":"2010","journal-title":"J Epidemiol"},{"key":"10.1016\/j.vhri.2017.07.009_bib18","first-page":"145","article-title":"Utility study of a basic database collected from patients with diabetes mellitus in 15 hospitals by retrospective analysis","volume":"29","author":"Yanase","year":"2011","journal-title":"Pharma Medica"},{"key":"10.1016\/j.vhri.2017.07.009_bib19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/jjco\/hyr184","article-title":"Cancer incidence and incidence rates in Japan in 2006: based on data from 15 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project","volume":"42","author":"Matsuda","year":"2012","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.vhri.2017.07.009_bib20","unstructured":"Official Statistics of Japan. Population estimates (as of October 1 of 2010). 2013. Available from: http:\/\/www.e-stat.go.jp\/SG1\/estat\/eStatTopPortal.do. [Accessed October 21, 2013]."},{"key":"10.1016\/j.vhri.2017.07.009_bib21","unstructured":"Cancer Information Service. Cancer statistics in Japan: 5-year relative survival rate of cases diagnosed in 2006\u20132008 by sex (updated September 20, 2016). Available from: http:\/\/ganjoho.jp\/en\/professional\/statistics\/table_download.html. [Accessed May 24, 2017]."},{"key":"10.1016\/j.vhri.2017.07.009_bib22","unstructured":"Official Statistics of Japan. Estimates of national medical care expenditure 2010. 2013. Available from: http:\/\/www.e-stat.go.jp\/SG1\/estat\/eStatTopPortal.do. [Accessed August 14, 2014]."}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109917300559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109917300559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T01:22:13Z","timestamp":1570065733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109917300559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":22,"alternative-id":["S2212109917300559"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2017.07.009","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resource Use and Cost of Treating Human Papillomavirus\u2013Related Lesions in Japanese Women","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2017.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc. on behalf of International Society for Pharmacoeconomics and Outcomes Research (ISPOR).","name":"copyright","label":"Copyright"}]}}